P731 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Medexus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 2.36 EUR

Market Cap: €57.7m

	Medexus Pharmaceuticals Inc F:P731	CA
P	Perusahaan Perkebunan London Sumatra Indonesia Tbk PT XMUN:PS9A	ID
S	Sixt SE OTC:SIXGF	DE
S	Shionogi & Co Ltd XMUN:SH0	JP
Q	Quanta Services Inc F:QAA	US
	Telus International Cda Inc F:5Z9	CA
N	NU Skin Enterprises Inc SWB:NUS	US

Profitability Summary

Medexus Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

54%

Strong 3Y Average Gross Margin

53%

Declining Gross Margin

56% > 54%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

8% > 4%

Negative Net Margin

Low 3Y Average Net Margin

Declining Net Margin

1% > 0%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

16%

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-2% > 44%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.